Home › Compare › TAPM vs MRK

TAPM vs MRK: Dividend Comparison 2026

TAPM yields 809.72% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TAPM wins by $3072022.53M in total portfolio value
10 years
TAPM
TAPM
● Live price
809.72%
Share price
$0.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3072022.56M
Annual income
$2,471,571,165,957.82
Full TAPM calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — TAPM vs MRK

📍 TAPM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTAPMMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TAPM + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TAPM pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TAPM
Annual income on $10K today (after 15% tax)
$68,825.91/yr
After 10yr DRIP, annual income (after tax)
$2,100,835,491,064.15/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, TAPM beats the other by $2,100,835,490,256.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TAPM + MRK for your $10,000?

TAPM: 50%MRK: 50%
100% MRK50/50100% TAPM
Portfolio after 10yr
$1536011.29M
Annual income
$1,235,785,583,454.06/yr
Blended yield
80.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TAPM
No analyst data
Altman Z
-6.2
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TAPM buys
0
MRK buys
0
No recent congressional trades found for TAPM or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTAPMMRK
Forward yield809.72% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$3072022.56M ✓$30.7K
Annual income after 10y$2,471,571,165,957.82 ✓$950.29
Total dividends collected$3024635.26M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TAPM vs MRK ($10,000, DRIP)

YearTAPM PortfolioTAPM Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$91,672$80,971.66$11,192$351.54+$80.5K → TAPM
2$791,809$693,720.23$12,524$392.70+$779.3K → TAPM
3$6,447,208$5,599,972.18$14,015$438.65+$6.43M → TAPM
4$49,512,617$42,614,105.02$15,682$489.96+$49.50M → TAPM
5$358,832,255$305,853,754.29$17,547$547.23+$358.81M → TAPM
6$2,455,549,204$2,071,598,691.56$19,632$611.16+$2455.53M → TAPM
7$15,876,313,093$13,248,875,444.54$21,963$682.53+$15876.29M → TAPM
8$97,044,091,291$80,056,436,281.36$24,571$762.18+$97044.07M → TAPM
9$561,169,523,232$457,332,345,550.85$27,486$851.08+$561169.50M → TAPM
10$3,072,022,555,816$2,471,571,165,957.82$30,745$950.29+$3072022.53M → TAPM

TAPM vs MRK: Complete Analysis 2026

TAPM — Stock

Tapinator, Inc. develops and publishes mobile games and applications on the iOS, Google Play, and Amazon platforms in North America and Europe. The company's library includes approximately 300 titles, such as Video Poker Classic and Crypto Trillionaire. It also provides in-app purchase and subscription services. The company was founded in 2013 and is headquartered in New York, New York.

Full TAPM Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this TAPM vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TAPM vs SCHDTAPM vs JEPITAPM vs OTAPM vs KOTAPM vs MAINTAPM vs JNJTAPM vs ABBVTAPM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.